Testing a memory drug for women with anorexia
Treatments studied
Part of Mental health clinical trials.
This trial tests whether donepezil, a medication used in memory disorders, can help women with the restrictive subtype of anorexia nervosa. It may improve symptoms by affecting brain chemicals related to appetite and mood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 65 years old.
- You have been diagnosed with anorexia nervosa, restrictive type, with a BMI between 15 and 18.5.
- You are using a highly effective form of birth control.
- You have not taken any psychiatric medications (like antidepressants) in the last 3 weeks.
- You do not have a history of certain other eating disorders, schizophrenia, bipolar disorder, asthma, stomach ulcers, seizures, or serious heart or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication (donepezil) to help people with anorexia nervosa change habits related to eating. The study wants to see if the medicine is safe and can help reduce restrictive eating patterns.
This trial compares donepezil (a medicine for Alzheimer’s symptoms) against a non-drug treatment plan. It aims to see which approach helps people with Alzheimer’s who still have measurable thinking ability and specific Alzheimer’s test results.
This study tests whether a memory medication called donepezil (Aricept) can help strengthen bones in people with memory problems. If you have mild cognitive impairment or dementia and are not already on a similar medication, you may be able to join.
This study looks at how well people with Alzheimer’s disease (AD) or mild cognitive impairment (MCI) perform on standardized memory/brain tests. It may help researchers understand changes over time, and whether certain types of brain signals or test results track with the condition.
This trial tests whether a surgery called lymphatic-venous anastomosis, when added to the Alzheimer's medication donepezil, is more effective than donepezil alone. It may help improve memory and thinking by clearing waste from the brain.
This Phase 2 study tests whether donepezil, along with structured cognitive (brain) training, can improve outcomes for people with alcohol use disorder. It will measure whether this combination helps after recent heavy drinking, while tracking safety over about 13 weeks.
Hear when a new Anorexia Nervosa Restricting Type trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.